y 27632 has been researched along with Parkinson Disease, Secondary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, C; Huang, J; Lai, W; Leng, F; Li, G; Liu, W; Liu, Y; Sheng, F; Tang, Q; Wang, Q; Zhang, Q; Zhang, R; Zhou, M | 1 |
| Inan, SY; Sahin, AS; Soner, BC | 1 |
2 other study(ies) available for y 27632 and Parkinson Disease, Secondary
| Article | Year |
|---|---|
ROCK1 induces dopaminergic nerve cell apoptosis via the activation of Drp1-mediated aberrant mitochondrial fission in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Amides; Animals; Apoptosis; Dopamine; Dopaminergic Neurons; Dynamins; Gene Expression Regulation; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Mitochondrial Dynamics; Oxidative Stress; Parkinson Disease, Secondary; PC12 Cells; Pyridines; Rats; rho-Associated Kinases; Signal Transduction; Substantia Nigra | 2019 |
Behavioural effects of basal ganglia rho-kinase inhibition in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
Topics: Amides; Animals; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Enzyme Inhibitors; Male; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Pyridines; Rats; rho-Associated Kinases | 2016 |